[HTML][HTML] Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections

CML Wager, FL Wormley Jr - Mucosal immunology, 2014 - Elsevier
Macrophages are innate immune cells that possess unique abilities to polarize toward
different phenotypes. Classically activated macrophages are known to have major roles in …

[HTML][HTML] Increased susceptibility to pneumonia due to tumour necrosis factor inhibition and prospective immune system rescue via immunotherapy

R Ha, Y Keynan, ZV Rueda - Frontiers in Cellular and Infection …, 2022 - frontiersin.org
Immunomodulators such as tumour necrosis factor (TNF) inhibitors are used to treat
autoimmune conditions by reducing the magnitude of the innate immune response …

Mechanisms of action of vitamin D as supplemental therapy for Pneumocystis pneumonia

GS Lei, C Zhang, BH Cheng… - Antimicrobial agents and …, 2017 - Am Soc Microbiol
The combination of trimethoprim and sulfamethoxazole (TMP-SMX) is the most effective
regimen for therapy of Pneumocystis pneumonia (PCP). As many patients with PCP are …

Fatal cytomegalovirus infection in an adult with inherited NOS2 deficiency

SB Drutman, D Mansouri, SA Mahdaviani… - … England Journal of …, 2020 - Mass Medical Soc
Background Cytomegalovirus (CMV) can cause severe disease in children and adults with a
variety of inherited or acquired T-cell immunodeficiencies, who are prone to multiple …

Differential macrophage polarization from pneumocystis in immunocompetent and immunosuppressed hosts: potential adjunctive therapy during pneumonia

V Nandakumar, D Hebrink, P Jenson… - Infection and …, 2017 - Am Soc Microbiol
We explored differential polarization of macrophages during infection using a rat model of
Pneumocystis pneumonia. We observed enhanced pulmonary M1 macrophage polarization …

PD-1 Deficiency Promotes Macrophage Activation and T-Helper Cell Type 1/T-Helper Cell Type 17 Response in Pneumocystis Pneumonia

C Zhang, HM Rong, T Li, K Zhai… - American Journal of …, 2020 - atsjournals.org
Pneumocystis is an unusual, opportunistic fungal pathogen capable of causing
Pneumocystis pneumonia (PCP) in immunocompromised hosts. Although PCP was …

[HTML][HTML] Pneumocystis jirovecii pneumonia mortality risk associated with preceding long-term steroid use for the underlying disease: A multicenter, retrospective …

K Miyake, S Senoo, R Shiiba, J Itano, G Kimura… - PloS one, 2024 - journals.plos.org
Objective Long-term steroid use increases the risk of developing Pneumocystis pneumonia
(PcP), but there are limited reports on the relation of long-term steroid and PcP mortality …

[HTML][HTML] All-Trans Retinoic Acid in Combination with Primaquine Clears Pneumocystis Infection

GS Lei, C Zhang, S Shao, HW Jung, PJ Durant… - PLoS …, 2013 - journals.plos.org
Pneumocystis pneumonia (PcP) develops in immunocompromised patients. Alveolar
macrophages play a key role in the recognition, phagocytosis, and degradation of …

Nitric Oxide in Mucormycosis Pathogenesis

AYL Soare - 2023 - search.proquest.com
Mucormycosis is classified by NIAID as an emerging disease and is caused by Mucorales
fungi. The recent surge of mucormycosis cases among COVID-19 patients has thrust the …

[HTML][HTML] Pneumocystis Pneumonia: Checkpoint Inhibition to the Rescue?

J Better, U Matt - American Journal of Respiratory Cell and …, 2020 - atsjournals.org
The fungus Pneumocystis jiroveci causes pneumonia only in immunosuppressed patients,
such as in advanced human immunodeficiency virus (HIV) infection or after organ …